Division 2.1.3 Benzimidazoles and pro-benzimidazoles

United Kingdom

‘

Pharmacologically active substance(s) Marker residue Animal species MRLs Target tissues Other provisions
Netobimin Sum of albendazole oxide, albendazole sulphone and albendazole 2-aminosulphone, expressed as albendazole X1Bovine, ovine 100 μg/kg Muscle For oral use only
100 μg/kg Fat
1 000 μg/kg Liver
500 μg/kg Kidney
100 μg/kg Milk

’

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Netobimin	Sum of albendazole oxide, albendazole sulphone and albendazole 2-aminosulphone, expressed as albendazole	X1Bovine, ovine	100 μg/kg	Muscle	For oral use only
100 μg/kg	Fat
1 000 μg/kg	Liver
500 μg/kg	Kidney
100 μg/kg	Milk

Annotations

Editorial notes

X1: Substituted by Corrigendum to Commission Regulation (EC) No 807/2001 of 25 April 2001 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Official Journal of the European Communities L 118 of 27 April 2001).